Social Pulse: Regeneron Pharmaceuticals Inc (REGN.OQ)
REGN.OQ on NASDAQ Stock Exchange Global Select Market
271.42USD
12:55pm EDT
271.42USD
12:55pm EDT
Price Change (% chg)
$-6.87 (-2.47%)
$-6.87 (-2.47%)
Prev Close
$278.29
$278.29
Open
$277.64
$277.64
Day's High
$277.64
$277.64
Day's Low
$271.36
$271.36
Volume
68,696
68,696
Avg. Vol
220,530
220,530
52-wk High
$283.00
$283.00
52-wk Low
$131.50
$131.50
- Cramer's Lightning Round - Regeneron Is The Real Deal (7/31/13)
- Cramer Quick Take: What's Next for Biotech?
- Cramer's Mad Money - Facebook's Triumph (7/25/13)
- Ohr Phramaceuticals: Eye Drop Treatment For Wet AMD Could Sideline Eylea Momentum
- Sanofi, Amgen, Pfizer In Race For New Cholesterol Drug
- 4 Noteworthy Upgrades That You Should Question
Press Releases
- EYLEA® (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
- Regeneron Named Biotechnology Company of the Year
- Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
- EYLEA® (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe
- ZALTRAP® (ziv-aflibercept) Receives CHMP Positive Opinion in the European Union for Previously Treated Metastatic Colorectal Cancer

